Geoffrey C. Gillespie - Mar 15, 2024 Form 3 Insider Report for Orthofix Medical Inc. (OFIX)

Role
CAO
Signature
/s/ Geoffrey C. Gillespie
Stock symbol
OFIX
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
3
Date filed
3/19/2024, 04:35 PM
Previous filing
Jan 9, 2024
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OFIX Common Stock 37.2K Mar 15, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OFIX Employee Stock Option (Right to Buy) Mar 15, 2024 Common Stock 11.2K $20.90 Direct F2
holding OFIX Employee Stock Option (Right to Buy) Mar 15, 2024 Common Stock 11K $13.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of 1,692 share of Common Stock directly owned by Reporting Person and 35,511 unvested restricted stock units, of which, 101 units will vest on December 15, 2024, 291 units will vest on April 1, 2024, 292 units will vest on April 1, 2025, 615 units will vest on February 1, 2025, 615 units will vest on February 1, 2026, 1,552 units will vest on January 5, 2025, 1,552 units will vest on January 5, 2026, 2,459 units will vest on January 31, 2025, 23,331 units will vest on October 15, 2025, 1,567 units will vest on January 8, 2025, 1,568 units will vest on January 8, 2026, and 1,568 units will vest on January 8, 2027.
F2 The options were granted on January 5, 2023 and will vest and become exercisable with respect to one-third (1/3rd) or the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.
F3 The options were granted on January 8, 2024 and will vest and become exercisable with respect to one-third (1/3rd) or the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.